The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Randolph Sophia since 2021.
This trader's CIK number is 1817127.
At the time of last reporting, Randolph Sophia was the CHIEF MEDICAL OFFICER of Alx Oncology Holdings Inc. (stock ticker symbol ALXO).
Also see all insider trading activities at Alx Oncology Holdings Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ALXO | 0 | $0 | 16,638 | $217,494 | 0 | $0 |
| 2023 | ALXO | 0 | $0 | 3,222 | $29,680 | 12,829 | $46,184 |
| 2022 | ALXO | 0 | $0 | 0 | $0 | 46,474 | $167,306 |
| 2021 | ALXO | 0 | $0 | 66,593 | $3,921,597 | 53,852 | $156,985 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-14 | ALXO | Sale | 1,365 | 2.58 | 3,521 |
| 2024-07-01 | ALXO | Sale | 3,273 | 5.82 | 19,045 |
| 2024-05-13 | ALXO | Sale | 12,000 | 16.24 | 194,928 |
| 2023-06-30 | ALXO | Sale | 1,605 | 7.34 | 11,780 |
| 2023-06-09 | ALXO | Option Ex | 12,829 | 3.60 | 46,184 |
| 2022-12-29 | ALXO | Sale | 1,617 | 11.07 | 17,900 |
| 2022-12-16 | ALXO | Option Ex | 46,474 | 3.60 | 167,306 |
| 2021-12-15 | ALXO | Option Ex | 23,852 | 1.45 | 34,585 |
| 2021-11-22 | ALXO | Option Ex | 30,000 | 4.08 | 122,400 |
| 2021-11-22 | ALXO | Sale | 14,884 | 36.77 | 547,314 |
| 2021-10-11 | ALXO | Sale | 7,387 | 61.07 | 451,131 |
| 2021-09-10 | ALXO | Sale | 7,387 | 77.48 | 572,374 |
| 2021-08-10 | ALXO | Sale | 7,387 | 64.80 | 478,707 |
| 2021-07-12 | ALXO | Sale | 7,387 | 55.36 | 408,922 |
| 2021-05-10 | ALXO | Sale | 7,387 | 62.65 | 462,773 |
| 2021-04-12 | ALXO | Sale | 7,387 | 60.52 | 447,053 |
| 2021-03-10 | ALXO | Sale | 7,387 | 74.91 | 553,323 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Randolph Sophia (CHIEF MEDICAL OFFICER of Alx Oncology Holdings Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.